- Category
- Micro (2024-25)
- Udyam number
- UDYAM-WB-10-0000539

Indopath Clinical Private Limited
About Indopath Clinical Private Limited
Data last updated:
Indopath Clinical Private Limited is a private limited company based in Kolkata, West Bengal, India. It operates in the diagnostic centers and pathology labs segment of the healthcare sector. It was incorporated on 30 January 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U74900WB2015PTC205138.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹3 Lakh. It is led by directors Ravi Kumar Agarwal and Rajshree Agarwal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Kolkata, West Bengal.
As per the financials filed for FY 2022, the company reported a revenue of ₹89.3 Lakh, a growth of 102% compared to the previous year. For the same year it recorded a net profit of ₹3.96 Lakh (net margin 4.4%) and EBITDA of ₹7.59 Lakh (EBITDA margin 8.5%). Revenue has grown at a compounded annual rate (CAGR) of 21% over three years and 18% over five years.
Indopath Clinical Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-WB-10-0000539). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Recognitions & Rankings of Indopath Clinical
Contact details
Indopath Clinical Private Limited's registered office is in Kolkata, West Bengal. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address54 Shibnath Shastri Sarani 38 Block – B, 3rd Floor New Alipore, Kolkata, West Bengal, India – 700053
- IndustryHealthcare, Diagnostic Centers & Pathology Labs
To see the full contact details of Indopath Clinical Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Indopath Clinical Private Limited
FY 2025 filings availableIndopath Clinical Private Limited reported revenue of ₹89.3 Lakh (up 102% YoY) for FY 2022.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 18% over five years, including 102% growth in the latest year. EBITDA rose 144% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹89.3 Lakh | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹7.59 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹3.96 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 8.5% | ||||
| Net Profit Margin | 4.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Indopath Clinical Private Limited, buy the company report.
Board of directors of Indopath Clinical Private Limited
Indopath Clinical has 2 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ravi Kumar Agarwal | Director | 15 Apr 2025 | 1 Years 6 Months | Current |
| Rajshree Agarwal Also directs: Healfinity Solutions Private Limited | Director | 10 Jan 2024 | 2 Years 9 Months | Current |
Auditor
Indopath Clinical Private Limited is audited by S DHAR & CO for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S DHAR & CO | FY 2021 | 301045E |
Shareholding
The shareholding of Indopath Clinical Private Limited is on record for 4 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Indopath Clinical Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Indopath Clinical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Indopath Clinical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Indopath Clinical Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Indopath Clinical Private Limited has 7 board changes on record since 2021: 2 appointments and 5 cessations. The latest: Drishti Agarwal ceased to be Whole-Time Director on 15 Apr 2025.
Frequently asked questions
Indopath Clinical is an active private limited company based in Kolkata, West Bengal, India. The company works in diagnostic centers and pathology labs, within the healthcare industry. It was incorporated on 30 January 2015 (11+ years old) and is registered under CIN U74900WB2015PTC205138.
Indopath Clinical has 2 current directors:
- Ravi Kumar Agarwal - Director
- Rajshree Agarwal - Director
The latest financial statements of Indopath Clinical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Indopath Clinical is U74900WB2015PTC205138. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Indopath Clinical was incorporated on 30 January 2015, making it 11+ years old. It is registered with the Registrar of Companies, Kolkata.
Drishti Agarwal ceased to be Whole-Time Director on 15 Apr 2025. Ravi Kumar Agarwal was appointed as Director on 15 Apr 2025. Anant Agarwal ceased to be Director on 10 Jan 2024. Indopath Clinical has 7 board changes on record in total.
Yes, Indopath Clinical is registered as a micro enterprise under Udyam registration (number: UDYAM-WB-10-0000539).
The registered office of Indopath Clinical is at 54 Shibnath Shastri Sarani 38 Block – B, 3rd Floor New Alipore, Kolkata, West Bengal, India – 700053.
Indopath Clinical operates in the healthcare industry, in the diagnostic centers and pathology labs segment.
The compliance status of Indopath Clinical is compliant as of 21 September 2026. The company is actively filing with the Registrar of Companies.

